Industry specific information to provide guidance on the industry's complex changes, updates and challenges.
Orphan Drug Development Book
This book, available for purchase, was written by our co-founder, Dr Miroslav Reljanović, and is a foremost work on the Orphan Drug market.
Ergomed’s Evolution and Risk-Sharing Business Model In Practice – A Scrip Video Interview
Hear Ergomed’s Chief Business Officer, Andrew Mackie, talk to Scrip about our history and risk-sharing business model.